[ORGANIZATION]

EMS Sigma Pharma

Featured in 1 tracked story · first seen about 2 hours ago

Situations

[ACTIVE] [HEALTH] [BUSINESS] [CRIME] [US] [BR] [GB]

GLP‑1 market, usage, safety & new guidance

182 clusters · 649 sources · last updated about 7 hours ago

Latest: Brazil's SUS delays rollout of GLP‑1 weight‑loss drugs

GLP‑1 receptor agonists dominate modern obesity and diabetes therapy, now reaching primary‑care, tele‑health and Medicare, with the market projected near $105 bn by 2030. Safety monitoring confirms a modest alopecia sign